Search Results - iBoxes

Board	Last Update	Last Post	Posts
Kraig Biocraft Laboratories Inc	01/14/23 2:05 PM	31 minutes ago	286,517
Capstone Therapeutics Inc.		03/24/25 9:53 AM	223
Sonoma Pharmaceuticals		03/14/25 11:09 AM	174
Sanuwave Health Inc		03/07/25 8:50 AM	2,246
Mother Nature (WRATH)		01/01/25 6:54 PM	2,996
Regenicin Inc		12/24/24 5:14 PM	2,936
Arch Therapeutics Inc		09/28/24 11:47 PM	10,350
Lescarden, Inc. (fka LCAR)		03/09/23 5:02 PM	82
CCA Industries Inc.		04/18/22 10:12 PM	15
Theralase Technologies Inc (fka TLT.V)		02/27/20 2:14 PM	28
Fibrocell Science Inc		09/16/19 8:40 AM	7,054
Falconridge Oil Tech., Corp. (fka FROT)		05/13/19 2:16 PM	2,459
KollagenX Corp. (fka KGNX)		04/26/19 9:41 AM	8,414
Osiris Therapeutics Inc.		03/13/19 11:08 AM	268
Original (and some Classic) Quotes		02/14/19 7:09 AM	23
SPECULATION STOCKS		08/10/18 11:52 AM	426
Zylo Therapeutics (fka )		04/30/18 11:37 AM	5
Female Health Company		06/10/17 8:53 AM	77
AtriCure Inc.		01/30/17 11:31 AM	7
MELA Sciences, Inc.		11/12/15 1:11 PM	719
BIG GAME PROFIT HUNTERZZZ		06/30/11 9:12 AM	1,385
Pemco Aviation Group Inc		12/28/07 1:01 PM	2

Play Episode

6min

Proactive - Interviews for investors

Structural Monitoring Systems: 20% growth & cash flow milestone

Structural Monitoring Systems Executive Chairman and CEO Ross Love talked with Proactive about the company’s aviation-focused growth strategy, recent product developments, and financial performance. Love explained that the company operates across three segments: avionics for special mission fleets, contract manufacturing, and the development of CVM (Comparative Vacuum Monitoring) technology for detecting microscopic cracks in metal structures. He noted, “The investment case is this is a business that will grow at around about 20% a year plus or minus.” One of the highlights discussed was the launch of a compact version of their digital audio system, which is tailored for emergency services and aerial firefighting fleets. These products are increasingly in demand, with installations underway across North America, including for California’s CAL FIRE — the largest aerial firefighting fleet. Love also detailed their expansion into South America, which is facilitated by similar infrastructure to the North American market. He said, “We supply most of the critical flights across North America… we’re making inroads into Europe and into South America.” On the financial front, Love highlighted that the company has doubled in size over the last two and a half years and is now operating with positive cash flow for the first time, following a successful capital raise of over $8 million. The company expects its first commercial revenues from CVM technology in the first quarter of the next financial year. #StructuralMonitoringSystems #AviationTechnology #CVMTechnology #AerialFirefighting #EmergencyServices #AerospaceInnovation #PositiveCashFlow #ASXSMN #AviationGrowth #DigitalAudioSystem #SouthAmericaExpansion

Proactive - Interviews for investors

Candel Therapeutics shares positive survival data for investigational immunotherapy in NSCLC

Candel Therapeutics CEO Dr. Paul Peter Tak joined Steve Darling from Proactive to announce final survival data from a Phase 2a clinical trial evaluating the company’s investigational immunotherapy in patients with stage III/IV non-small cell lung cancer (NSCLC) who had an inadequate response to immune checkpoint inhibitor (ICI) treatment. The study reported a median overall survival (mOS) of 24.5 months in 46 evaluable patients who received two courses of the investigational therapy. In a subset of patients who had progressive disease at baseline despite ICI treatment, mOS was 21.5 months. Historically, similar patients receiving standard-of-care chemotherapy have had mOS between 9.8 and 11.8 months, with published studies rarely exceeding 12 months. With a median follow-up of 32.4 months, the data demonstrated long-term survival benefits, with 37% of patients who had progressive disease despite ICI therapy still alive two years after treatment. Based on these positive results, Candel Therapeutics will continue advancing the development program, including preparations for a potential registrational trial in patients with non-squamous histology NSCLC. The U.S. Food and Drug Administration (FDA) has previously granted Fast Track Designation for the investigational therapy in combination with an antiviral agent and ICI therapy for patients with stage III/IV NSCLC who are resistant to first-line PD-(L)1 inhibitors and do not have activating molecular driver mutations or have progressed on targeted therapy. These findings support the therapy’s potential as a new treatment option for NSCLC patients with limited alternatives. #proactiveinvestors #candeltherapeuticsinc #nasdaq #cadl #CancerTreatment #ViralTherapy #ProstateCancer #PancreaticCancer #Glioblastoma #PaulPeterTak #ClinicalTrials #BiotechNews #Immunotherapy #Oncology #CancerResearch

Proactive - Interviews for investors

Opioid-Free pain relief: AFT’s global expansion strategy

AFT Pharmaceuticals Ltd Managing Director Dr Hartley Atkinson talked with Proactive at the AIM's Small and Midcap Conference about the company's unique approach to drug development, its expanding global footprint, and what lies ahead in 2025. AFT Pharmaceuticals is focused on creating pharmaceuticals "with a difference," targeting unmet needs and reducing reliance on opioids. “We don’t sell anything we don’t believe in,” said Dr Atkinson, highlighting the importance of alternatives to opioid treatments. One of the company’s key analgesic products helps avoid opioid use — a particularly timely innovation in light of the global opioid crisis. Dr Atkinson discussed the company’s core markets, with a strong presence in New Zealand and Australia, generating approximately 150 million in revenue. AFT also maintains operations in Asia and now exports to around 80 countries. The company has experienced sustained growth, having quadrupled in size over the past decade and doubled in the last five years. AFT has established six new affiliates across regions including Singapore, Hong Kong, South Africa, Canada, the UK, and Europe. Looking ahead, the company plans several product launches across Australia and New Zealand and anticipates five drug launches in China — the world’s second-largest pharmaceutical market. “For us, that’s going to be an interesting journey,” Atkinson added. #AFTPharmaceuticals #OpioidAlternatives #PharmaceuticalInnovation #ChinaPharma #DrugDevelopment #HealthcareGrowth #ASXStocks #BiotechInvesting #GlobalHealthcare #PharmaExpansion

Proactive - Interviews for investors

Sprintex secures A$3.25m to expand global output; reduce debt

Sprintex Ltd (ASX:SIX) managing director and CEO Jay Upton talked with Proactive's Stephen Gunnion about the company’s successful A$3.25 million capital raise, drawing strong backing from both existing shareholders and new institutional investors. Upton said approximately A$1.5 million of the funds would go toward debt reduction, with the remaining A$1.75 million allocated to accelerating production and sales of Sprintex’s new range of high-speed electric compressors. These products aim to improve energy efficiency, offering “more than 50% energy savings versus the current benchmark products”. He discussed the company’s strategic manufacturing expansion, highlighting the transition of its Malaysian facility to support electric compressor production—mirroring current operations in Suzhou, China. This move is designed to double manufacturing capacity, navigate global trade sensitivities, and better serve regional preferences. Currently in the Netherlands, Upton also outlined a five-year partnership with Mest Water, a Dutch wastewater treatment firm focused on ammonia reduction in livestock manure—a project supported by the Dutch government. Sprintex will supply compressors for this initiative. Looking ahead, Sprintex is set to exhibit at the Hannover International Trade Fair in Germany, where the company expects to attract significant attention for its clean air and vacuum solutions across industries like aquaculture, semiconductors, textiles, and agriculture. For more interviews like this, visit Proactive’s YouTube channel. Don’t forget to like the video, subscribe, and enable notifications so you never miss an update. #Sprintex #CleanTech #IndustrialCompressors #EnergyEfficiency #GreenTechnology #CapitalRaise #Manufacturing #DutchTech #HannoverFair #VacuumTechnology #AsiaManufacturing #SustainableIndustry #AmmoniaReduction #ElectricCompressors

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

iBox Search Results

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

iBox Search Results

Go Ad-Free